News & Events

MICAP review the Deepbridge Technology Growth EIS

MI Capital Research Ltd (MICAP), providers of independent due diligence and researchers into the alternative investment market, have released the latest review of t

Deepbridge shortlisted for 2 awards!

Deepbridge has been shortlisted for 2 awards at the 2017 Growth Investor Awards, named as a finalist for the 'Best SEIS Investment Manager' award and the ,Flagship Growth Investor' Award.

Patient Capital Review – The Deepbridge Perspective

The Patient Capital Review, announced by the Government in February 2017, closed to consultation on the 22nd September.  Since then we have heard rumour, gossip and ‘insight’ in to how Government thinking is leading.  The general consensus is that the Government is not happy with the st

Deepbridge Announces Sky Medical Technology Exit

The Deepbridge investment team is delighted to announce that a partial exit has been delivered for investors in Sky Medical Technology Limited (Sky).

Deepbridge welcomes new team member

Deepbridge is delighted to welcome Lewis Tandy to the team as Marketing Executive.  Lewis is an Associate Member of the Chartered Institute of Marketing and holds an MSc in Management with Marketing and a BA Marke

EligoChem awarded up to $4.8M from CARB-X

Deepbridge investee company EligoChem has been warded up to $4.8M from CARB-X to select and develop antimicrobial peptides as


Experienced life sciences investment manager Deepbridge Capital has today (19 June 2017) announced the launch of Deepbridge Syndicate, an online investment platform created to facilitate investment by elective professional investors